Diseases, Conditions, Syndromes

Proteasome inhibitors show promise for drug-resistant malaria

Proteasome inhibitors have significant promise as components of novel combination therapies to treat multidrug-resistant malaria, according to a study published June 6 in the open-access journal PLOS Pathogens by David Fidock, ...

Diseases, Conditions, Syndromes

Combination drug treatment can cut malaria by 30 percent

Malaria infections among infants can be cut by up to 30 per cent when antimalarial drugs are given intermittently over a 12 month period, a three-year clinical trial in Papua New Guinea has shown.

Health informatics

Which voices led medical misinformation in the early stages of COVID?

In the early and thus far most devastating stages of the COVID-19 pandemic, scientists were at a near loss on how to treat the deadly disease. The public was desperate for information. Consequently, two antimalarial drugs—chloroquine ...

Diseases, Conditions, Syndromes

No new malaria cases in Europe, Caucasus or C.Asia in 2015

No new cases of malaria originated in Europe, Central Asia or the Caucasus in 2015, the first year without a transmission for almost 30 years, the World Health Organization said Wednesday.

Medical research

A promising therapeutic modality against the coronavirus

Since the emergence of the novel coronavirus in late 2019, multiple approaches for treating COVID-19 have been considered, from the use of repurposed medicines such as the antimalarial drug, hydroxychloroquine, to the Ebola ...

page 6 from 11